Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind placebo-controlled crossover trial of vardenafil in Raynaud's disease
2005-000295-41Phase 3Completed
- Sponsor
- University of Cologne
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of vardenafil in Raynaud disease (2 arms), sponsored by University of Cologne. Primary endpoints: Peripheral perfusion at room temperature, Peripheral perfusion at cold exposure and 1 more. Started Dec 2005; status: completed.
02
Drugs
vardenafil
03
Conditions
Raynaud disease
Beyond the preview
Go deeper on 2005-000295-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000295-41.